Haemonetics Corporation
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, inc…
Medical - Instruments & Supplies
US, Boston [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
Fundamentals
Valuation
| Metric | Q3 | Q4 | Δ in % | |
|---|---|---|---|---|
| EV/EBITDA | -11.58 | 63.83 | 72.19 | |
| Graham Fair Price | -18.58 | 13.06 | 16.04 | |
| PEG | 14.52 | -1.50 | 1.31 | |
| Price/Book | -1.88 | 4.52 | 4.60 | |
| Price/Cash Flow | -58.09 | 79.69 | -190.12 | |
| Prices/Earnings | 53.16 | 53.21 | 34.74 | |
| Price/Sales | -2.20 | 12.63 | 12.91 | |
| Price/FCF | -58.09 | 79.69 | -190.12 | |
| Naive Interpretation | member | |||
01 - Valuation ·
Bad
Fundamentals
Profitability
| Metric | Q3 | Q4 | Δ in % | |
|---|---|---|---|---|
| Gross Profit Margin | -5.50 | 0.50 | 0.53 | |
| Operating Margin | 9.00 | 0.15 | 0.14 | |
| ROA | -34.66 | < 0.005 | 0.01 | |
| ROE | 0.03 | 0.02 | -35.94 | |
| ROIC | 0.02 | 0.03 | 39.34 | |
| Naive Interpretation | member | |||
02 - Profitability ·
Not Interpreted
Fundamentals
Financial Growth
| Metric | Q3 | Q4 | Δ in % | |
|---|---|---|---|---|
| Debt QOQ | < 0.005 | 0.14 | -97.33 | |
| Dividends QOQ | 0.00 | 0.00 | 0.00 | |
| EBIT QOQ | 0.30 | 0.11 | -62.70 | |
| EPS QOQ | 0.27 | -0.35 | 33.75 | |
| FCF QOQ | -1.31 | 3.38 | 158.85 | |
| Revenue QOQ | 0.06 | 0.02 | -63.13 | |
| Naive Interpretation | member | |||
03 - Financial Growth ·
Balanced
Fundamentals
Leverage & Liquidity
| Metric | Q3 | Q4 | Δ in % | |
|---|---|---|---|---|
| Assets Turnover | n.A. | n.A. | n.A. | |
| Days Inventory Outstanding (DIO) | 172.76 | 166.28 | -3.75 | |
| Days Sales Outstanding (DSO) | 56.64 | 54.15 | -4.39 | |
| Inventory Turnover | 0.52 | 0.54 | 3.90 | |
| Debt/Capitalization | 0.48 | 0.46 | -4.27 | |
| Quick Ratio | 1.55 | 1.29 | -17.08 | |
| Naive Interpretation | member | |||
04 - Leverage & Liquidity ·
Weak
Fundamentals
Per Share Metrics
| Metric | Q3 | Q4 | Δ in % | |
|---|---|---|---|---|
| Book Value | 18.58 | 18.90 | 1.73 | |
| Cash | 3.84 | 3.55 | -7.54 | |
| Capex | -0.44 | -0.19 | 56.57 | |
| Free Cash Flow | -0.45 | 1.07 | 138.13 | |
| Revenue | 6.62 | 6.76 | 2.06 | |
| Naive Interpretation | member | |||
05 - Per Share Metrics ·
Positive
Fundamentals
Financial Health
06 - Financial Health ·
Bad